A detailed history of Freestone Capital Holdings, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 26,754 shares of LLY stock, worth $21.3 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
26,754
Previous 26,565 0.71%
Holding current value
$21.3 Million
Previous $24.1 Million 1.45%
% of portfolio
0.82%
Previous 0.86%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $145,934 - $181,443
189 Added 0.71%
26,754 $23.7 Million
Q2 2024

Nov 22, 2024

BUY
$724.87 - $909.04 $164,545 - $206,352
227 Added 0.86%
26,565 $24.1 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $164,545 - $206,352
227 Added 0.86%
26,565 $24.1 Million
Q1 2024

Nov 22, 2024

SELL
$592.2 - $792.28 $246,355 - $329,588
-416 Reduced 1.55%
26,338 $20.5 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $906,658 - $1.21 Million
1,531 Added 6.17%
26,338 $20.5 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $230,558 - $271,798
439 Added 1.8%
24,807 $14.5 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $139,538 - $192,375
-321 Reduced 1.3%
24,368 $13.1 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $274,629 - $367,211
783 Added 3.28%
24,689 $11.6 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $661,641 - $777,066
-2,130 Reduced 8.18%
23,906 $8.21 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $387,467 - $451,477
-1,205 Reduced 4.42%
26,036 $9.53 Million
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $1.44 Million - $1.64 Million
-4,857 Reduced 15.13%
27,241 $8.81 Million
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $857,094 - $1.01 Million
-3,075 Reduced 8.74%
32,098 $10.4 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $137,997 - $171,496
588 Added 1.7%
35,173 $10.1 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $305,796 - $379,494
1,360 Added 4.09%
34,585 $9.55 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $5,540 - $6,817
-25 Reduced 0.08%
33,225 $7.68 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $1.34 Million - $1.73 Million
7,427 Added 28.76%
33,250 $7.63 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $32,206 - $41,693
196 Added 0.76%
25,823 $4.82 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $2.97 Million - $3.94 Million
-22,797 Reduced 47.08%
25,627 $4.33 Billion
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $106,594 - $123,295
-729 Reduced 1.48%
48,424 $7.17 Million
Q2 2020

Aug 04, 2020

BUY
$136.42 - $164.18 $3.75 Million - $4.51 Million
27,480 Added 126.79%
49,153 $8.07 Million
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $147,741 - $182,861
-1,241 Reduced 5.42%
21,673 $3.01 Million
Q4 2019

Feb 04, 2020

BUY
$106.92 - $132.43 $58,806 - $72,836
550 Added 2.46%
22,914 $3.01 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $1,281 - $1,393
-12 Reduced 0.05%
22,364 $2.5 Million
Q2 2019

Aug 05, 2019

BUY
$110.79 - $129.32 $122,422 - $142,898
1,105 Added 5.19%
22,376 $2.48 Million
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $232,526 - $273,700
-2,089 Reduced 8.94%
21,271 $2.76 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $268,668 - $300,989
-2,537 Reduced 9.8%
23,360 $2.7 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $144,759 - $180,924
-1,686 Reduced 6.11%
25,897 $2.78 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $20,211 - $23,196
267 Added 0.98%
27,583 $2.35 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $66,863 - $78,927
901 Added 3.41%
27,316 $2.11 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $50,638 - $54,316
618 Added 2.4%
26,415 $2.23 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $20,192 - $22,411
262 Added 1.03%
25,797 $2.21 Million
Q2 2017

Aug 15, 2017

BUY
N/A
25,535
25,535 $2.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.